TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11037592

Group type: EXPERIMENTAL
Intervention: Electronic fetal monitoring (EFM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittent auscultation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scalp blood sampling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fetal pulse oximetry and ST-analysis of fetal ECG (STAN)
Number of subjects: 0
Study: 8769693

Group type: EXPERIMENTAL
Intervention: IFN‐alpha n1
Number of subjects: 527

Group type: COMPARATOR
Intervention: No IFN (standard chemotherapy: busulphan or hydroxyurea)
Number of subjects: 527
Study: 1732125

Group type: EXPERIMENTAL
Intervention: Naloxone infusions (0.2 micrograms.kg‐1.min‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 8
Study: 6482168

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tobramycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amikacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 31912603

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30719935

Group type: EXPERIMENTAL
Intervention: Brinzolamide
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 90

Group type: COMPARATOR
Intervention: Artificial tear (Sodium hyaluronate)
Number of subjects: 90
Study: 30016756

Group type: EXPERIMENTAL
Intervention: High-noise workdays (76.8 dBA, SD: 6.2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-noise workdays (61.0 dBA, SD: 7.1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Post-shift personal noise exposure
Number of subjects: 40
Study: 27099761

Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation (ASV)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Oxygen therapy
Number of subjects: 43
Study: 24864063

Group type: EXPERIMENTAL
Intervention: Simplified DA-CPR instructions
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional DA-CPR instructions
Number of subjects: 75
Study: 20877298

Group type: EXPERIMENTAL
Intervention: Bumetanide, Frusemide, Torsemide
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: C825T in GNB3
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Val32Met in ANP
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Ter152Arg in ANP
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: ANP Arg152-alleles
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: ACE insertion/deletion polymorphism
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Gly460Trp in ADD1
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: GNB3 T-alleles
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Common genetic impact
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Pharmacokinetics
Number of subjects: 95
Study: 19287176

Group type: EXPERIMENTAL
Intervention: 8-week vocal training program (n = 14)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No-training control group (n = 29)
Number of subjects: 43
Study: 17615974

Group type: EXPERIMENTAL
Intervention: Detection of DD3 mRNA in urine of prostate cancer patients
Number of subjects: 80

Group type: COMPARATOR
Intervention: Detection of DD3 mRNA in urine of BPH patients
Number of subjects: 80

Group type: COMPARATOR
Intervention: Detection of DD3 mRNA in urine of healthy male volunteers
Number of subjects: 80
Study: 15016558

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 269

Group type: COMPARATOR
Intervention: Latanoprost 0.005%
Number of subjects: 269
Study: 11668421

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin certoparin (8000 antifactor Xa U b.i.d.)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Adjusted-dose intravenous unfractionated heparin (UFH)
Number of subjects: 393
Study: 9835755

Group type: EXPERIMENTAL
Intervention: 150 micrograms of oral clonidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8208915

Group type: EXPERIMENTAL
Intervention: Dual-chamber pacing (DDD)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Single-chamber ventricular demand pacing (VVI)
Number of subjects: 16
Study: 2659295

Group type: EXPERIMENTAL
Intervention: Aztreonam
Number of subjects: 69

Group type: COMPARATOR
Intervention: AMG
Number of subjects: 69
Study: 31511563

Group type: EXPERIMENTAL
Intervention: Psychoactive compounds (CANDO platform predictions)
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Specific tryptamines
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Cannabinoids
Number of subjects: 428
Study: 29061968

Group type: EXPERIMENTAL
Intervention: Olodaterol 5 µg QD via Respimat®
Number of subjects: 1379

Group type: COMPARATOR
Intervention: Formoterol 12 µg BID
Number of subjects: 1379

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1379
Study: 25211714

Group type: EXPERIMENTAL
Intervention: POWER intervention (8 sessions)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Control (single standard-of-care STI prevention session)
Number of subjects: 521
Study: 24386960

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A injection (50 U injected intracutaneously into 6-20 sites)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Surgical excision of the apocrine glands
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A injection
Number of subjects: 150
Study: 21733136

Group type: EXPERIMENTAL
Intervention: Foster Care (FC)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 136
Study: 18572184

Group type: EXPERIMENTAL
Intervention: Absence of resolution group (group 2)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Partial resolution group (group 1)
Number of subjects: 81
Study: 17334286

Group type: EXPERIMENTAL
Intervention: Total disc replacement (TDR)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Circumferential fusion
Number of subjects: 17

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 17
Study: 14723752

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg by mouth followed in two days by vaginal then oral misoprostol (Aberdeen regimen)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Dilation and evacuation (D&E)
Number of subjects: 18
Study: 12805252

Group type: EXPERIMENTAL
Intervention: Carbohydrate meal (3.43 MJ, 166g carbohydrates, 38g proteins)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Fat meal (3.35 MJ, 70g fat, 36g proteins)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 19
Study: 10355844

Group type: EXPERIMENTAL
Intervention: Pyruvate supplementation (6 g/d)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 7721404

Group type: EXPERIMENTAL
Intervention: Irbesartan 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Irbesartan 50 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2201664

Group type: EXPERIMENTAL
Intervention: Oral L-Dopa
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7030443

Group type: EXPERIMENTAL
Intervention: Chlorpromazine plus high dose propranolol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Chlorpromazine alone
Number of subjects: 10
Study: 31084292

Group type: EXPERIMENTAL
Intervention: Clinician intervention (DECIDE‐PC training sessions)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Patient activation and depression symptoms
Number of subjects: 312
Study: 27609528

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy
Number of subjects: 71
Study: 25575201

Group type: EXPERIMENTAL
Intervention: Universal adhesives (two types)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Self-etch adhesive (Clearfil SE)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Etch-and-rinse mode
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Self-etch mode
Number of subjects: 120
Study: 25329583

Group type: EXPERIMENTAL
Intervention: S-100 calcium-binding protein B (S-100B) levels
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory II (BDI-II) scores at baseline and discharge
Number of subjects: 50

Group type: COMPARATOR
Intervention: Baseline S-100B levels, high-sensitivity C-reactive protein, interleukin-6 levels
Number of subjects: 50
Study: 22938011

Group type: EXPERIMENTAL
Intervention: Massage after moisturizer application
Number of subjects: 13

Group type: COMPARATOR
Intervention: No massage after moisturizer application
Number of subjects: 13
Study: 19112224

Group type: EXPERIMENTAL
Intervention: Iodixanol (Visipaque) 50 mL
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Iohexol (Omnipaque) 50 mL
Number of subjects: 62
Study: 17660641

Group type: EXPERIMENTAL
Intervention: Toothbrush with bristle design 1
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Toothbrush with bristle design 2
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Toothbrush with bristle design 3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Toothbrush with bristle design 4
Number of subjects: 16
Study: 15134985

Group type: EXPERIMENTAL
Intervention: 153Sm-lexidronam
Number of subjects: 152

Group type: COMPARATOR
Intervention: 152Sm (placebo)
Number of subjects: 152
Study: 12420197

Group type: EXPERIMENTAL
Intervention: Self-measurements of BP and heart rate in GP's room
Number of subjects: 210
Study: 9438458

Group type: EXPERIMENTAL
Intervention: AutoPap 300 QC System
Number of subjects: 14914

Group type: COMPARATOR
Intervention: Random QC process (10% random selection)
Number of subjects: 14914
Study: 8285510

Group type: EXPERIMENTAL
Intervention: Multichannel cochlear implants
Number of subjects: 48
Study: 3549804

Group type: EXPERIMENTAL
Intervention: 2% minoxidil solution
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 3% minoxidil solution
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 30578883

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 25830322

Group type: EXPERIMENTAL
Intervention: rVSV-ZEBOV vaccine (3 million PFU, 20 million PFU, or 100 million PFU)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: rVSV-ZEBOV vaccine (20 million PFU or 100 million PFU)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: rVSV-ZEBOV vaccine (second dose at day 28)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: rVSV-ZEBOV vaccine
Number of subjects: 78
Study: 26655169

Group type: EXPERIMENTAL
Intervention: Single running suture technique
Number of subjects: 162
Study: 24527419

Group type: EXPERIMENTAL
Intervention: Nutrition counseling (2 sessions + 1 cooking class)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard care (brochures recommending phytochemical rich diet)
Number of subjects: 61
Study: 20865423

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (ECC group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Concentric exercise (CON group)
Number of subjects: 24
Study: 19034471

Group type: EXPERIMENTAL
Intervention: 50 mug misoprostol intravaginally every 4 h to a maximum of five doses
Number of subjects: 112

Group type: COMPARATOR
Intervention: 10 mg dinoprostone vaginal insert for a maximum of 12 h
Number of subjects: 112
Study: 17523399

Group type: EXPERIMENTAL
Intervention: Allicor (a long‐action garlic‐based preparation) administered for 12 months
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Allicor (a long‐action garlic‐based preparation)
Number of subjects: 51
Study: 15342615

Group type: EXPERIMENTAL
Intervention: Oral levosimendan 2 to 8 mg daily
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11532109

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 1860

Group type: COMPARATOR
Intervention: Control (non-ACE inhibitor regimens)
Number of subjects: 1860
Study: 9778329

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy in NYHA class I
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy in NYHA class II
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy in NYHA class III
Number of subjects: 603
Study: 8201808

Group type: EXPERIMENTAL
Intervention: Comics, photos, and poems to induce emotion
Number of subjects: 1220

Group type: EXPERIMENTAL
Intervention: General emotional intensity scale
Number of subjects: 1220
Study: 3297521

Group type: EXPERIMENTAL
Intervention: Constant positive airway pressure (CPAP) with an expiratory pressure of 12 cm H2O applied at one hour following extubation, and at daily intervals for the first five days following surgery for a continuous period of three hours
Number of subjects: 34

Group type: COMPARATOR
Intervention: No CPAP treatment
Number of subjects: 34
Study: 2201225

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg intramuscularly followed by 10 mg 4-hourly as required
Number of subjects: 80

Group type: COMPARATOR
Intervention: Morphine 10 mg intramuscularly 4-hourly as required
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study: 12114

Group type: EXPERIMENTAL
Intervention: fominoben
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 31387559

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) and lung ultrasound (LUS)-guided antibiotic therapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) only-guided therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 28203001

Group type: EXPERIMENTAL
Intervention: Bone graft therapy combined with CGFs
Number of subjects: 31

Group type: COMPARATOR
Intervention: Bone graft therapy alone
Number of subjects: 31
Study: 26047890

Group type: EXPERIMENTAL
Intervention: Esmirtazapine 1.5 mg
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Esmirtazapine 3.0 mg
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Esmirtazapine 4.5 mg
Number of subjects: 526

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Esmirtazapine (all doses)
Number of subjects: 526
Study: 23291105

Group type: EXPERIMENTAL
Intervention: High-dose vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: PBS control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant control
Number of subjects: 0
Study: 21692409

Group type: EXPERIMENTAL
Intervention: Proximal steroid injection (triamcinolone acetonide 20 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Distal steroid injection (triamcinolone acetonide 20 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: NCS (nerve conduction studies)
Number of subjects: 19
Study: 19058842

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotic drugs (amisulpride, clozapine, olanzapine, risperidone)
Number of subjects: 21533

Group type: COMPARATOR
Intervention: Second-generation antipsychotic drugs
Number of subjects: 21533
Study: 16436844

Group type: EXPERIMENTAL
Intervention: Double-lumen tube
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Univent tube
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Arndt Blocker
Number of subjects: 66
Study: 14969634

Group type: EXPERIMENTAL
Intervention: Blinded assessment of the carotid pulse by cardiologists
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Applanation tonometry on the radial pulse
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Applanation tonometry on the carotid pulse
Number of subjects: 46
Study: 11401629

Group type: EXPERIMENTAL
Intervention: 0.5% atropine with multi‐focal glasses
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: multi‐focal glasses
Number of subjects: 227

Group type: COMPARATOR
Intervention: single vision spectacles
Number of subjects: 227
Study: 9099195

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 3127

Group type: EXPERIMENTAL
Intervention: Medium-dose aspirin
Number of subjects: 3127

Group type: COMPARATOR
Intervention: Both interventions (low-dose and medium-dose aspirin)
Number of subjects: 3127
Study: 8135165

Group type: EXPERIMENTAL
Intervention: Acupuncture point SP-10
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-acupuncture point
Number of subjects: 0
Study: 3104964

Group type: EXPERIMENTAL
Intervention: Mecamylamine pretreatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo pretreatment
Number of subjects: 0
Study: 31456496

Group type: EXPERIMENTAL
Intervention: Automated telephonic intervention
Number of subjects: 21971

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 21971

Group type: EXPERIMENTAL
Intervention: Automated telephonic intervention (among those who completed the call)
Number of subjects: 21971
Study: 28064421

Group type: EXPERIMENTAL
Intervention: Counseling about sleep location emphasizing safe sleep practices to reduce SIDS risk
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: Counseling about sleep location emphasizing safe sleep practices to prevent SIDS/suffocation
Number of subjects: 1194

Group type: COMPARATOR
Intervention: Group assignment (intervention vs control)
Number of subjects: 1194
Study: 25303950

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupuncture point stimulation (TEAS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Mock TEAS
Number of subjects: 68
Study: 23992438

Group type: EXPERIMENTAL
Intervention: Breath Powered™ nasal delivery of 16-mg sumatriptan powder
Number of subjects: 20

Group type: COMPARATOR
Intervention: 20-mg liquid nasal spray
Number of subjects: 20

Group type: COMPARATOR
Intervention: 100-mg oral tablet
Number of subjects: 20

Group type: COMPARATOR
Intervention: 6-mg subcutaneous injection
Number of subjects: 20
Study: 20971632

Group type: EXPERIMENTAL
Intervention: mIROX (irinotecan plus oxaliplatin 85 mg/m(2))
Number of subjects: 479

Group type: COMPARATOR
Intervention: FUFIRI (irinotecan 80 mg/m(2), 5‐fluorouracil 2000 mg/m(2), folinic acid 500 mg/m(2) weekly times 6)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: mIROX
Number of subjects: 479

Group type: COMPARATOR
Intervention: FUFIRI
Number of subjects: 479
Study: 18983928

Group type: EXPERIMENTAL
Intervention: Low-dose theophylline
Number of subjects: 26

Group type: COMPARATOR
Intervention: Tulobuterol
Number of subjects: 26
Study: 17194276

Group type: EXPERIMENTAL
Intervention: Citalopram 20 to 60 mg/day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 12094123

Group type: EXPERIMENTAL
Intervention: 15 g Cr.H2O
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 10459398

Group type: EXPERIMENTAL
Intervention: Amino acid mixture with tryptophan (TRP)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Amino acid mixture without tryptophan (placebo)
Number of subjects: 27
Study: 7572251

Group type: EXPERIMENTAL
Intervention: Daily lithium dosing (800 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Every second day lithium dosing (1200 mg/every second day)
Number of subjects: 50
Study: 1971170

Group type: EXPERIMENTAL
Intervention: Ropinirol 0.4 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ropinirol 0.8 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ropinirol 1 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ropinirol (all doses)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 33376

Group type: EXPERIMENTAL
Intervention: Diazepam (5‐10 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (0.4‐0.8 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 29925498

Group type: EXPERIMENTAL
Intervention: Show Me Health Plans tool
Number of subjects: 1069
Study: 27460104

Group type: EXPERIMENTAL
Intervention: Novel device for ETT cleaning used every 8 hours
Number of subjects: 74

Group type: COMPARATOR
Intervention: Institutional standard of care (blind tracheal suction)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Novel device for ETT cleaning
Number of subjects: 74
Study: 24352342

Group type: EXPERIMENTAL
Intervention: 0.10% RLP068
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 0.30% RLP068
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 0.50% RLP068
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 22281412

Group type: EXPERIMENTAL
Intervention: Varespladib
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 20871948

Group type: COMPARATOR
Intervention: Ca(OH)₂ paste
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vitapex paste
Number of subjects: 30
Study: 17458641

Group type: EXPERIMENTAL
Intervention: Bupivacaine continuous epidural infusion with clonidine (5 microg.ml(‐1))
Number of subjects: 68

Group type: COMPARATOR
Intervention: Bupivacaine continuous epidural infusion without clonidine (control group)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Bupivacaine continuous epidural infusion with clonidine
Number of subjects: 68
Study: 15450693

Group type: EXPERIMENTAL
Intervention: Written disclosure intervention (participants wrote each week for 3 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control writing group
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Written disclosure intervention
Number of subjects: 35
Study: 12021091

Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 0
Study: 10450120

Group type: EXPERIMENTAL
Intervention: Legs crossed (method 1)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Legs crossed (method 2)
Number of subjects: 103
Study: 7503082

Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ephedrine
Number of subjects: 8
Study: 2190005

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 474042

Group type: EXPERIMENTAL
Intervention: 5 mg cyproterone acetate
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10 mg cyproterone acetate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (3 months prior to treatment)
Number of subjects: 8